# Adalimumab-ryvk

NDC: 82009-158
Generic name: adalimumab-ryvk
Labeler / Manufacturer: Quallent Pharmaceuticals Health LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: SUBCUTANEOUS
Marketing started: 20240731

FDA application: BLA761299

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82009-158"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82009-158
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dce1590f-9e47-4c4d-9437-cfb18b779a75